Citadel Advisors’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.3K Sell
18,900
-700
-4% -$1.04K ﹤0.01% 12622
2025
Q4
$32.9K Buy
+19,600
New +$33.7K ﹤0.01% 12196
2025
Q2
Sell
-11,000
Closed -$11.1K 14320
2025
Q1
$11.1K Sell
11,000
-12,300
-53% -$16.4K ﹤0.01% 13505
2024
Q4
$37.5K Buy
23,300
+2,800
+14% +$4.56K ﹤0.01% 12668
2024
Q3
$37.1K Buy
20,500
+12,200
+147% +$21.2K ﹤0.01% 12235
2024
Q2
$12.8K Sell
8,300
-14,800
-64% -$26.9K ﹤0.01% 12967
2024
Q1
$49.7K Buy
23,100
+16,375
+243% +$31.7K ﹤0.01% 12177
2023
Q4
$8.81K Sell
6,725
-1,575
-19% -$1.94K ﹤0.01% 13191
2023
Q3
$11K Buy
8,300
+800
+11% +$1.21K ﹤0.01% 13038
2023
Q2
$11.7K Sell
7,500
-1,675
-18% -$3.23K ﹤0.01% 13123
2023
Q1
$23.5K Sell
9,175
-5,775
-39% -$18.3K ﹤0.01% 12941
2022
Q4
$47.8K Buy
14,950
+1,425
+11% +$5.36K ﹤0.01% 12198
2022
Q3
$47K Buy
13,525
+3,225
+31% +$13.5K ﹤0.01% 11679
2022
Q2
$38K Sell
10,300
-4,300
-29% -$21.9K ﹤0.01% 12094
2022
Q1
$97K Sell
14,600
-8,100
-36% -$50K ﹤0.01% 12313
2021
Q4
$159K Sell
22,700
-3,425
-13% -$29.1K ﹤0.01% 12192
2021
Q3
$240K Sell
26,125
-9,300
-26% -$95.3K ﹤0.01% 11570
2021
Q2
$405K Buy
35,425
+4,150
+13% +$47.2K ﹤0.01% 10530
2021
Q1
$434K Buy
+31,275
New +$362K ﹤0.01% 10002
2020
Q4
Sell
-5,900
Closed -$25K 11341
2020
Q3
$25K Sell
5,900
-875
-13% -$4.56K ﹤0.01% 9811
2020
Q2
$42K Buy
6,775
+1,550
+30% +$10.4K ﹤0.01% 9379
2020
Q1
$42K Buy
+5,225
New +$47.4K ﹤0.01% 9102

Other funds holding OGI

Citadel Advisors's OGI Position: Q1 2026 in Review

Citadel Advisors reduced its Organigram Holdings (OGI) stake by 97% in Q1 2026, selling an estimated $721K and leaving 13,487 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12692.

Citadel Advisors first reported a position in OGI in Q3 2019 and has held it in 23 quarters since. The position peaked at $3.74M in Q4 2021. 73 funds tracked by Wall St. Rank hold OGI as of Q1 2026.

  • Citadel Advisors held 13,487 shares of Organigram Holdings worth $18.1K as of Q1 2026.
  • Citadel Advisors sold 485,265 Organigram Holdings shares in Q1 2026, an estimated $721K.
  • Organigram Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12692 holding.
  • Citadel Advisors first reported a position in Organigram Holdings in Q3 2019 and has held it in 23 quarters since.
  • Citadel Advisors's Organigram Holdings position peaked at $3.74M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.